Piperazine
This substance was identified for action under the Chemicals Management Plan (CMP).
Information sheet
| CAS RN | DSL name | Final assessment | Conclusion on section 64 criteria | Follow-up activities |
|---|---|---|---|---|
| 110-85-0 | Piperazine | HTML | Does not meet | Significant New Activity (SNAc) provisions |
Follow-up activities
Although piperazine is not considered to be harmful to human health or to the environment at current levels of exposure, this substance is associated with effects of concern. Therefore, there may be a concern if exposures were to increase. For this reason, the proposed follow-up activity is to apply the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA) to piperazine.
| Date | Activity |
|---|---|
| May 11, 2024 | Publication in the Canada Gazette, Part I: Vol. 158, No. 19, of a notice of intent to amend the Domestic Substances List to apply the SNAc provisions of CEPA and start of a 60-day public comment period. |
| May 11, 2024 | Publication of the final assessment. The related notice was published in the Canada Gazette, Part I: Vol. 158, No. 19. |
| March 13, 2021 | Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 11. |
Page details
- Date modified: